{"id":422810,"date":"2023-06-11T11:08:03","date_gmt":"2023-06-11T14:08:03","guid":{"rendered":"https:\/\/acaopopular.net\/jornal\/?p=422810"},"modified":"2023-06-11T11:08:03","modified_gmt":"2023-06-11T14:08:03","slug":"anvisa-aprova-primeiro-medicamento-injetavel-para-prevencao-do-hiv","status":"publish","type":"post","link":"https:\/\/acaopopular.net\/jornal\/anvisa-aprova-primeiro-medicamento-injetavel-para-prevencao-do-hiv\/","title":{"rendered":"Anvisa aprova primeiro medicamento injet\u00e1vel para preven\u00e7\u00e3o do HIV"},"content":{"rendered":"<div class=\"row visible-lg\">\n<div class=\"col-xs-12\">\n<div class=\"noticias-single__tags\"><\/div>\n<\/div>\n<\/div>\n<div class=\"row\">\n<div class=\"col-xs-12 col-lg-3\">\n<div class=\"noticias-single__meta\">\n<div class=\"noticias-single__author\">\n<div>Estad\u00e3o Conte\u00fado<\/div>\n<\/div>\n<div class=\"noticias-single__date\"><\/div>\n<div class=\"noticias-single__share \">\n<div class=\"noticias-single__share-item noticias-single__share-item--whatsapp noticias-single__share-item--whatsapp--desktop  \"><\/div>\n<div class=\"noticias-single__share-item noticias-single__share-item--more   \"><\/div>\n<\/div>\n<div class=\"noticias-single__content-area__left\">\n<div class=\"col-xs-12 col-lg-12 col-md-12 \">\n<div id=\"CW3677\" class=\"publicidade publicidade-responsive1  \">\n<div id=\"brasilemundo_300x250_02\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"col-xs-12 col-lg-9\">\n<div class=\"row\">\n<div class=\"col-xs-12\">\n<div class=\"noticias-single__image\"><picture class=\"noticias-single__picture\"><source srcset=\"https:\/\/correio-cdn1.cworks.cloud\/fileadmin\/_processed_\/0\/9\/csm_drugs-g1e03b6e61_1280_c529dc1f92.jpg\" media=\"(min-width: 420px)\" \/><img decoding=\"async\" class=\"noticias-single__image-source\" src=\"https:\/\/correio-cdn2.cworks.cloud\/fileadmin\/_processed_\/0\/9\/csm_drugs-g1e03b6e61_1280_13a4caf5ac.jpg\" alt=\"Anvisa aprova primeiro medicamento injet\u00e1vel para preven\u00e7\u00e3o do HIV\" \/><\/picture><span class=\"noticias-single__image-caption\">(Pixabay)<\/span><\/div>\n<\/div>\n<div class=\"col-xs-12 noticias-single__stick-parent\">\n<div class=\"row\">\n<div class=\"col-xs-12 col-md-7 col-lg-7\">\n<div class=\"row\">\n<div class=\"col-xs-12\">\n<h1 class=\"noticias-single__title noticias-single__title--desktop noticias-single__title--with-image visible visible-lg\"><\/h1>\n<div class=\"noticias-single__description visible-lg\"><strong>Ser\u00e1 mais uma op\u00e7\u00e3o de profilaxia pr\u00e9-exposi\u00e7\u00e3o (PreP)<\/strong><\/div>\n<div class=\"noticias-single__content-area noticias-single__content-area--before-content\">\n<div class=\"chamada-assinatura\"><\/div>\n<\/div>\n<div class=\"noticias-single__content is-blocked\">\n<div class=\"noticias-single__content__text js-mediator-article\">\n<p class=\"bodytext\">A Ag\u00eancia Nacional da Vigil\u00e2ncia Sanit\u00e1ria (Anvisa) aprovou o primeiro medicamento injet\u00e1vel para preven\u00e7\u00e3o do HIV no Brasil, o Cabotegravir, que ser\u00e1 mais uma op\u00e7\u00e3o de profilaxia pr\u00e9-exposi\u00e7\u00e3o (PreP), ou seja, uso cont\u00ednuo de medicamentos antirretrovirais para pessoas com maior risco de contamina\u00e7\u00e3o.<\/p>\n<p class=\"bodytext\">A autoriza\u00e7\u00e3o foi dada \u00e0 empresa GSK (GlaxoSmithKline) e est\u00e1 na Resolu\u00e7\u00e3o n\u00ba 1.970, de 1\u00ba de junho de 2023, publicada no Di\u00e1rio Oficial da Uni\u00e3o no \u00faltimo dia 5 de junho.<\/p>\n<div class=\"single-publicidade\">\n<div id=\"brasilemundo_300x250_01\"><\/div>\n<\/div>\n<p class=\"bodytext\">Atualmente, os medicamentos \u00e0 disposi\u00e7\u00e3o do p\u00fablico s\u00e3o comprimidos de uso via oral. A principal diferen\u00e7a em rela\u00e7\u00e3o aos novos est\u00e1 em sua a\u00e7\u00e3o prolongada, com redu\u00e7\u00e3o da necessidade de doses.<\/p>\n<p class=\"bodytext\">Basicamente, aplica-se uma inje\u00e7\u00e3o intramuscular na regi\u00e3o dos gl\u00fateos, com as duas doses iniciais tendo entre elas um intervalo de quatro semanas, e depois uma dose a cada oito semanas. Ou seja, em vez de 365 doses anuais, seriam apenas seis<\/p>\n<p class=\"bodytext\">Segundo informa\u00e7\u00f5es divulgadas pela GSK em 2020, a efic\u00e1cia do novo m\u00e9todo seria 69% maior em rela\u00e7\u00e3o aos medicamentos de uso oral e di\u00e1rio. Al\u00e9m disso, espera-se que, com doses menos frequentes, a ades\u00e3o ao tratamento aumente para os que fizerem uso desse tipo de medicamento.<\/p>\n<div class=\"single-publicidade\">\n<div id=\"internas_300x250_03\"><\/div>\n<\/div>\n<p class=\"bodytext\">Para mais informa\u00e7\u00f5es sobre efic\u00e1cia, seguran\u00e7a e quem deve recorrer ao m\u00e9todo da PReP, \u00e9 poss\u00edvel acessar o site e documentos do Minist\u00e9rio da Sa\u00fade (ainda sem atualiza\u00e7\u00e3o em rela\u00e7\u00e3o aos injet\u00e1veis).<\/p>\n<\/div>\n<div id=\"paywall-barreiras-trial\" class=\"modal hide paywall-barreiras-inread paywall-barreiras--trial-wall is-active\" tabindex=\"-1\" role=\"dialog\" data-type=\"trial\" data-base-url=\"https:\/\/assine.correio24horas.com.br\/v2\" data-enable-modal=\"false\" data-enable-swg=\"true\" data-sku-plan=\"basic_monthly\" data-chartbeat=\"false\">\n<div class=\"paywall-barreiras-inread__content\">\n<div class=\"paywall-barreiras-inread__header\"><\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Ser\u00e1 mais uma op\u00e7\u00e3o de profilaxia pr\u00e9-exposi\u00e7\u00e3o (PreP)<\/p>\n","protected":false},"author":5,"featured_media":422811,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[327,6],"tags":[],"class_list":["post-422810","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multimidia","category-municipios"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/acaopopular.net\/jornal\/wp-content\/uploads\/2023\/06\/ceringa.jpg","_links":{"self":[{"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/posts\/422810","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/comments?post=422810"}],"version-history":[{"count":0,"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/posts\/422810\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/media\/422811"}],"wp:attachment":[{"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/media?parent=422810"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/categories?post=422810"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/acaopopular.net\/jornal\/wp-json\/wp\/v2\/tags?post=422810"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}